Experiences in fertility preservation: Lessons learned to ensure that fertility and reproductive autonomy remain options for cancer survivors

Journal of Assisted Reproduction and Genetics

Volumn 30, Issue 10, 2013, Pages 1263-1270

  Noyes, Nicole ^a   Melzer, Katherine ^a   Druckenmiller, Sarah ^a   Fino, M Elizabeth ^a   Smith, Meghan ^a   Knopman, Jaime M ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer survivor; Embryo cryopreservation; Fertility preservation; Oocyte cryopreservation; Quality of life

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GANIRELIX; HUMAN MENOPAUSAL GONADOTROPIN; LETROZOLE; LEUPRORELIN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANALGESIA; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BODY MASS; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURVIVOR; CENTRAL NERVOUS SYSTEM TUMOR; CHRONIC MYELOID LEUKEMIA; COOLING; CRYOPRESERVATION; DIGESTIVE SYSTEM CANCER; DRUG DOSE INCREASE; EMERGENCY WARD; ENDOMETRIUM CANCER; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; GESTATIONAL AGE; HODGKIN DISEASE; HOSPITALIZATION; HUMAN; HYSTERECTOMY; INTERDISCIPLINARY COMMUNICATION; INTRADUCTAL CARCINOMA; LIVE BIRTH; LUTEAL PHASE; MAJOR CLINICAL STUDY; MEDIASTINUM MASS; MESOTHELIOMA; METAPHASE; NONHODGKIN LYMPHOMA; OOCYTE; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARY CANCER; OVARY FOLLICLE; OVARY HYPERSTIMULATION; PATIENT COUNSELING; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; REPRODUCTIVE PROCEDURE; RHABDOMYOSARCOMA; THAWING; THROMBOCYTE TRANSFUSION; THYROID CANCER; TRANSVAGINAL ECHOGRAPHY; UROGENITAL TRACT CANCER; UTERINE CERVIX CANCER; VITRIFICATION; VULVA CANCER; WARMING; ZYGOTE;

ADULT; CRYOPRESERVATION; FEMALE; FERTILITY PRESERVATION; HUMANS; INFERTILITY, FEMALE; NEOPLASMS; OOCYTES; OVARY; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; REPRODUCTIVE HEALTH; SURVIVORS; ZYGOTE;

EID: 84888006116     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-013-0066-2     Document Type: Article

References (41)

1. Azim AA, Costantini-Ferrando M, Oktay M. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008;26:2630-5.
2. Baynosa J, Westphal L, Madrigrano A, Wapnir I. Timing of breast cancer treatments with oocyte retrieval and embryo cryopreservation. J Am Coll Surg. 2009;209:603-7.
3. Byrne J, Rasmussen SA, Steinhorn SC, Connelly RR, Myers MH, Lynch CF, et al. Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet. 1998;62:45-52.
4. Chiva L, Lapuente F, Gonzalez-Cortijo L, Carballo N, Garcia JF, Rojo A, et al. Sparing fertility in young patients with endometrial cancer. Gynecol Oncol. 2008;111:S101-4.
5. Cobo A, Meseguer M, Remohi J, Pellicer A. Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum Reprod. 2010;25:2239-46.
6. Das M, Shehata F, Son WY, Tulandi T, Holzer H. Ovarian reserve and response to IVF and in vitro maturation treatment following chemotherapy. Hum Reprod. 2012;27:2509-14.
7. Diaz J, Sonoda Y, Leitao M, Zivanovic O, Vrown C, Chi D, et al. Oncologic outcome of fertility-sparing radical trachelectomy vs. radical hysterectomy for stage 1B1 cervical carcinoma. Gynecol Oncol. 2008;111:255-60.
8. Dolmans MM, Demylle D, Martinez-Madrid B, Donnez J. Efficacy of in vitro fertilization after chemotherapy. Fertil Steril. 2005;83:897-901.
9. Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril. 2008;89:84-91.
10. Ginsburg ES, Yanushpolsky EH, Jackson KV. In vitro fertilization for cancer patients and survivors. Fertil Steril. 2001;75:705-10.
11. Goodwin PJ, Ennis M, Pritchard KI, Trudeau M, Hood N. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol. 1999;17:2365-70.
12. Grifo JA, Noyes N. Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients. Fertil Steril. 2010;93:609-15.
13. Han AR, Kwon YS, Kim DY, Kim JH, Kim YM, Kim YT, et al. Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia. Int J Gynecol Cancer. 2009;19:147-51.
14. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, http://seer.cancer. gov/csr/1975-2009-pops09/, based on November 2011 SEER data submission, posted to the SEER web site, 2012. Website accessed: 1/31/12.
15. Ichinose M, Fujimoto A, Osuga Y, Minaguchi T, Kawana K, Yano T, et al. The influence of infertility treatment on the prognosis of endometrial cancer and atypical complex endometrial hyperplasia. Int J Gynecol Cancer. 2013;23:288-93.
16. Knopman JM, Papadopoulos E, Grifo J, Fino ME, Noyes N. Surviving childhood and reproductive age malignancy: effects of treatment on fertility, gametes and future parenthood. Lancet Oncol. 2010;11:490-8.
17. Li FP, Fine W, Jaffe N, Holmes GE, Holmes FF. Offspring of patients treated for cancer in childhood. J Natl Cancer Inst. 1979;62:1193-7.
18. Meirow D. Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers. Leuk Lymphoma. 1999;33:66-76.
19. Noyes N, Abu-Rustum N, Ramirez P, Plante M. Options in the management of fertility-related issues after radical trachelectomy in patients with early cervical cancer. Gynecol Oncol. 2009;114:117-20.
20. Noyes N, Porcu E, Borini A. With more than 900 babies born, live birth outcomes following oocyte cryopreservation do not appear different from those occurring after conventional IVF. Reprod Biomed Online. 2009;18:769-76.
21. Noyes N, Knopman J, Labella P, McCaffrey C, Clark-Williams M, Grifo J. Oocyte cryopreservation outcomes including pre-cryo and post-thaw meiotic spindle evaluation following slow cooling and vitrification of human oocytes. Fertil Steril. 2010;94:2078-82.
22. Noyes N, Knopman J, Long K, Coletta J, Abu-Rustum N. Fertility considerations in the management of gynecologic malignancies. Gynecol Oncol. 2011;120:326-33.
23. Noyes N, Knopman J, Melzer K, Fino ME, Friedman B, Westphal L. Oocyte cryopreservation as a fertility preservation measure for cancer patients. Reprod Biomed Online. 2011;23:323-33.
24. Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab. 2006;91:3885-90.
25. Park JY, Seong SJ, Kim TJ, Kim JW, Kim SM, Bae DS, et al. Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer. Obstet Gynecol. 2013;121:136-42.
26. Parmegiani L, Cognigni GE, Bernardi S, Cuomo S, Ciampaglia W, Infante FE, et al. Efficiency of aseptic open vitrification and hermetical cryostorage of human oocytes. Reprod Biomed Online. 2011;23:505-12.
27. Partridge A, Gelber S, Gelber RD, Castiglione-Gertsch M, Goldhirsch A, Winer E. Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI. Eur J Cancer. 2007;43:1646-53.
28. Practice Committee of the Society for Assisted Reproductive Technology. Practice Committee of the American Society for Reproductive Medicine: Essential elements of informed consent for elective oocyte cryopreservation: a practice committee opinion. Fertil Steril. 2008;90:S134-5.
29. Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99:37-43.
30. Reddy J, Oktay K. Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer. Fertil Steril. 2012;98:1363-9.
31. Reh A, Lu L, Weinerman R, Grifo J, Krey L, Noyes N. Treatment outcomes and quality-of-life assessment in a university-based fertility preservation program: results of a registry of female cancer patients at 2 years. J Assist Reprod Genet. 2011;28:635-41.
32. Rienzi L, Romano S, Albricci L, Maggiulli R, Capalbo A, Baroni E, et al. Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Hum Reprod. 2010;25:66-73.
33. Ruddy KJ, Partridge AH. The unique reproductive concerns of young women with breast cancer. Adv Exp Med Biol. 2012;732:77-787.
34. Rudick B, Opper N, Paulson R, Bendikson K, Chung K. The state of oocyte cryopreservation in the United States. Fertil Steril. 2010;94:2642-6.
35. Schover LR, Rybicki LA, Martin BA, Bringelsen KA. Having children after cancer. A pilot survey of survivors' attitudes and experiences. Cancer. 1999;86:530-5.
36. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.
37. Socie G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A, et al. Nonmalignant late affects after allogeneic stem cell transplantation. Blood. 2003;101:3373-85.
38. Wang CB, Wang CJ, Huang HJ, et al. Fertility-preserving treatment in young patients with endometrial adenocarcinoma. Cancer. 2002;94:2192-8.
39. Waring AB, Wallace WH. Subfertility following treatment for childhood cancer. Hosp Med. 2000;61:550-7.
40. Werner M, Reh A, Labella P, Noyes N. Laboratory evaluation in oocyte cryopreservation suggests retrieved oocytes are comparable whether frozen for medical indications, deferred reproduction or oocyte donation. J Assist Reprod Genet. 2010;27:613-7.
41. www.sart.org (accessed website 6/26/2012).